Likes
Followers
Subscribers
Followers

Tuesday, December 10, 2024
About Us
Website Terms of Use
Privacy Policy
Contact

The Dales Report - We Set The Narrative - We Set The Narrative

Cannabis
Psychedelics
Crypto
AI/Tech
Small Caps
Podcasts
Reports
Facebook
Twitter
YouTube
Instagram

Home
COMP 360

Browsing Tag

COMP 360

COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb…

Jun 28, 2021

The Unofficial Atai Life Sciences Pre-IPO Deep Dive: What Investors Need To Know

Jun 15, 2021

Canaccord Initiates Coverage On Compass Pathways With Bullish Price Target

Oct 13, 2020

Why MindMed Could Be a Better Relative Value to Compass Pathways

Sep 28, 2020

// //

Latest Articles

How Trump’s Appointments View The Future Of Cannabis

Dec 8, 2024

The Latest: Organigram Acquires Motif & ALJ Hearing Schedule

Dec 6, 2024

Cannabis Trends And Market Moves In Pennsylvania For 2025

Dec 5, 2024

ALJ Hearing: December Cannabis Rescheduling Updates

Dec 3, 2024

Popular Interviews

Trump, Gaetz, and Cannabis: A High-Stakes Political Move

Nov 15, 2024

Rick Wiley Predicts Trumps Stance on Cannabis

Nov 12, 2024

Gaetz Is Out, Pam Bondi Is In. What Happens To Cannabis?

Nov 22, 2024

Village Farms Q3 2024 Earnings, And Senate Leader Announced

Nov 14, 2024

TDR

CANNABIS
PSYCHEDELICS
CRYPTOCURRENCY
AI/TECHNOLOGY
PODCASTS
TRENDS

© 2024 - The Dales Report. All Rights Reserved.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Daily up-to-date information directly in your inbox

Baked In Newsletter

Email: